Browse

Home
People
Departments & Colleges
Research
Research Area Overlaps

P32 Jak inhibitors Tofacitinib and Ruxolitinib do not improve functional deficits in dystrophin-deficient mdx mice

About

©2026 VIVO Project | Terms of Use | Powered by VIVO and the Web of Science (© 2026 Clarivate Analytics)